You are right franciss. It's a complex situation.
Perhaps AXO management is facing an almighty dilemma. Unlike a producer like GRR with significant cash flows, AXO has finite cash and pressing event horizons.
I am surpised at this late stage that with most of the boxes ticked in terms of relevant approvals and outcome of studies, the funding solution is still in doubt.
In any case, AXO is a far better quality investment choice than say GWR.
